Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin

This publication has 36 references indexed in Scilit:

• Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia
  Clinical Microbiology and Infection, 2006
• In Vitro Activity of Tigecycline against Isolates from Patients Enrolled in Phase 3 Clinical Trials of Treatment for Complicated Skin and Skin‐Structure Infections and Complicated Intra‐Abdominal Infections
  Clinical Infectious Diseases, 2005
• Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline
  International Journal of Antimicrobial Agents, 2005
• Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae recovered from adult patients with community-acquired pneumonia in an Argentinian teaching hospital
  International Journal of Antimicrobial Agents, 2005
• Comparative Antimicrobial Susceptibility of Respiratory Tract Pathogens
  Chemotherapy, 2004
• Treatment Costs of Community-Acquired Pneumonia in an Employed Population
  Chest, 2004
• A prediction rule to identify allocation of inpatient care in community-acquired pneumonia
  European Respiratory Journal, 2003
• Epidemiology of community-acquired pneumonia in adults: a population-based study
  European Respiratory Journal, 2000
• Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis
  JAMA, 1996
• THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL
  Biometrika, 1934